Hopefully yes, for our sake. It could go either way though. Personally, I reckon it will be successful. $1.25 is cheap considering they will get their SAMR really soon.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025